Folke Per-Olof Wallström
Vorsitzender bei CAMURUS AB
Vermögen: 5 Mio $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Sven Fredrik Tiberg | M | 61 |
Camurus Development AB
| 22 Jahre |
Markus Johnsson | M | 52 | 18 Jahre | |
Anders Gersel Pedersen | M | 73 | 6 Jahre | |
Christer Lennart Samuelsson | M | 70 | 1 Jahre | |
Andreas Eggert | M | 56 | 6 Jahre | |
Nina Korfu-Pedersen | F | 51 | 2 Jahre | |
Fredrik Joabsson | M | 52 | 23 Jahre | |
Hans Olof Gunnar Johansson | M | 70 | 6 Jahre | |
Søren Tulstrup | M | 59 | 6 Jahre | |
Agneta Svedberg | F | 61 | 9 Jahre | |
Stig Anders Lindberg | M | 52 | 3 Jahre | |
Lisa Albertsson | F | - | 1 Jahre | |
Henrik Jacobsson | M | 55 | 2 Jahre | |
Jon U. Garay Alonso | M | 51 | 2 Jahre | |
Annette Mattsson | F | 58 | 7 Jahre | |
Thomas Fritz | M | 60 | 5 Jahre | |
Tiziana di Martino | M | 48 | 5 Jahre | |
Max Sakajja | M | 43 | 7 Jahre | |
Richard Jameson | M | 60 | 8 Jahre | |
Hege Hellstrom | M | 59 | 4 Jahre | |
Mario Gualano | M | 55 | 4 Jahre | |
Karin Fischer | F | 48 | 1 Jahre | |
Torsten Malmström | M | 56 | 11 Jahre | |
Stefan K. Persson | M | 57 | 2 Jahre | |
Finn Albrechtsen | M | 57 | 1 Jahre | |
Henk Doude van Troostwijk | M | - | 8 Jahre | |
Lars Erik Backemar | M | 74 |
Arosgruppen Fastigheter Fjärdingen AB
| - |
Maria Lundqvist | F | - | 3 Jahre | |
Erika Johanna Söderberg Johnson | F | 54 | 1 Jahre | |
Alberto Pedroncelli | M | - | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Göran Arvidson | M | 64 |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | 2 Jahre |
Ulf Arne Wiinberg | M | 66 | 6 Jahre | |
Birgit Stattin Norinder | F | 75 | - | |
Marianne Dicander Alexandersson | F | 65 | 5 Jahre | |
Karin Hansson | M | 61 | 5 Jahre | |
Lena Winstedt | M | 55 | - | |
Johannes G. C. P. Schikan | M | 66 | 3 Jahre | |
Behshad Sheldon | F | 61 | 6 Jahre | |
Angelica Loskog | M | 51 | 3 Jahre | |
Charlotta Göransson | M | 52 | 6 Jahre | |
Anders Lundin | M | 60 | 5 Jahre | |
Kerstin Valinder-Strinnholm | F | 64 | 9 Jahre | |
Eva-Maria Joed | F | 55 | - | |
Martin Fredrik Jonsson | M | 63 | - | |
Per-Anders Abrahamsson | M | 75 | 14 Jahre | |
Cindy Wong | M | 65 | 4 Jahre | |
Karl Blom | M | 55 | 2 Jahre | |
Bo Jesper Hansen | M | 66 |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | 16 Jahre |
Jon Aron Olof Heimer | M | 57 | 7 Jahre | |
Bo Krister Håkansson | M | 78 | 13 Jahre | |
Svein Arild Mathisen | M | 68 | 8 Jahre | |
Björn Eskil Olsson | M | 79 | 6 Jahre | |
Eva Pinotti Lindqvist | F | 61 | 8 Jahre | |
Anna Cherouvrier Hansson | F | 51 | - | |
Cecilia Callmer | F | 50 | - | |
Karin Aschan | F | 63 | 3 Jahre | |
Samuel Agus | M | 56 | 1 Jahre | |
Fredrik Lindgren | M | 54 | - | |
Ole Vahlgren | M | 61 | 4 Jahre | |
Mark Never | M | 63 | - | |
Rolf Classon | M | 79 |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | 3 Jahre |
Dag Åke Ulf Landegren | M | 72 | - | |
Gudrun Hörnquist | M | - |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | 15 Jahre |
Thomas Lennart Eklund | M | 57 |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | 6 Jahre |
Claes E. Wilhelmsson | M | 85 |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | 6 Jahre |
Marcus Storch | M | 82 | 4 Jahre | |
Mattias Larsson | M | - |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | - |
Nils-Göran Pettersson | M | 79 |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | 6 Jahre |
Alf Gunnar Martin Nicklasson | M | 69 |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | 3 Jahre |
Steven Glazer | M | 76 | - | |
Lena Louise Nilsson | F | 57 |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | 6 Jahre |
Urban Paulsson | M | 60 | 4 Jahre | |
Rein Piir | M | 66 | - | |
Andrew Firth McLean | M | 59 | 1 Jahre | |
Peter Myrenfors | M | - |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | 3 Jahre |
Mats Blom | M | 59 |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | 3 Jahre |
Kennet Rooth | M | 69 |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | 5 Jahre |
Kerstin Edung | F | - |
Swedish Orphan International Holding AB
Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | - |
Peter Hjelmström | M | 51 | 3 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Schweden | 79 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Folke Per-Olof Wallström
- Persönliches Netzwerk